Vitalhub Corp. (TSE:VHI - Get Free Report) fell 0.8% during mid-day trading on Thursday . The company traded as low as C$7.79 and last traded at C$7.92. 61,890 shares changed hands during trading, a decline of 54% from the average session volume of 133,303 shares. The stock had previously closed at C$7.98.
Wall Street Analysts Forecast Growth
VHI has been the subject of several recent analyst reports. Cormark lifted their target price on shares of Vitalhub from C$7.50 to C$8.00 in a report on Tuesday, June 11th. Canaccord Genuity Group lifted their target price on shares of Vitalhub from C$7.50 to C$8.00 and gave the stock a "buy" rating in a report on Monday, May 13th.
Read Our Latest Research Report on Vitalhub
Vitalhub Stock Down 2.8 %
The firm has a market capitalization of C$391.55 million, a PE ratio of 72.00, a PEG ratio of 1.18 and a beta of 1.25. The stock's fifty day simple moving average is C$7.81 and its 200 day simple moving average is C$6.95.
Vitalhub (TSE:VHI - Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The company reported C($0.01) earnings per share for the quarter, missing analysts' consensus estimates of C$0.06 by C($0.07). The firm had revenue of C$16.24 million during the quarter, compared to the consensus estimate of C$15.39 million. Vitalhub had a return on equity of 4.73% and a net margin of 8.14%. On average, analysts predict that Vitalhub Corp. will post 0.120294 EPS for the current year.
About Vitalhub
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
